These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32304215)

  • 1. Hide and seek: interplay between influenza viruses and B cells.
    Kuraoka M; Adachi Y; Takahashi Y
    Int Immunol; 2020 Sep; 32(9):605-611. PubMed ID: 32304215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the conserved protective epitopes of hemagglutinin on influenza A viruses.
    Jiao C; Wang B; Chen P; Jiang Y; Liu J
    Front Immunol; 2023; 14():1086297. PubMed ID: 36875062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
    Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
    J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemagglutinin stalk-based monoclonal antibody elicits broadly reactivity against group 1 influenza A virus.
    Huang J; Huang N; Fan M; Zhao L; Luo Y; Ding P; Tian M; Liu Q; Guo Y; Zhao J; Zheng Y; Zhang H; Ping J
    Virol J; 2020 Dec; 17(1):191. PubMed ID: 33287849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Masking of antigenic epitopes by antibodies shapes the humoral immune response to influenza.
    Zarnitsyna VI; Ellebedy AH; Davis C; Jacob J; Ahmed R; Antia R
    Philos Trans R Soc Lond B Biol Sci; 2015 Sep; 370(1676):. PubMed ID: 26194761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Novel Cross-Reactive Influenza B Virus Hemagglutinin Head Specific Antibodies That Lack Hemagglutination Inhibition Activity.
    Kirkpatrick E; Henry C; McMahon M; Jiang K; Strohmeier S; van Bakel H; Wilson PC; Krammer F
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32907980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.
    Kamlangdee A; Kingstad-Bakke B; Osorio JE
    J Virol; 2016 Aug; 90(15):6771-6783. PubMed ID: 27194759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice.
    Asthagiri Arunkumar G; Ioannou A; Wohlbold TJ; Meade P; Aslam S; Amanat F; Ayllon J; García-Sastre A; Krammer F
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies.
    Wang W; Song HS; Keller PW; Alvarado-Facundo E; Vassell R; Weiss CD
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Influenza B Universal Vaccine Candidates Using the "Mosaic" Hemagglutinin Approach.
    Sun W; Kirkpatrick E; Ermler M; Nachbagauer R; Broecker F; Krammer F; Palese P
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30944178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunodominance and Antigenic Variation of Influenza Virus Hemagglutinin: Implications for Design of Universal Vaccine Immunogens.
    Zost SJ; Wu NC; Hensley SE; Wilson IA
    J Infect Dis; 2019 Apr; 219(Suppl_1):S38-S45. PubMed ID: 30535315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
    Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
    J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine approaches conferring cross-protection against influenza viruses.
    Vemula SV; Sayedahmed EE; Sambhara S; Mittal SK
    Expert Rev Vaccines; 2017 Nov; 16(11):1141-1154. PubMed ID: 28925296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outflanking immunodominance to target subdominant broadly neutralizing epitopes.
    Angeletti D; Kosik I; Santos JJS; Yewdell WT; Boudreau CM; Mallajosyula VVA; Mankowski MC; Chambers M; Prabhakaran M; Hickman HD; McDermott AB; Alter G; Chaudhuri J; Yewdell JW
    Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13474-13479. PubMed ID: 31213541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
    Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals.
    Henry C; Zheng NY; Huang M; Cabanov A; Rojas KT; Kaur K; Andrews SF; Palm AE; Chen YQ; Li Y; Hoskova K; Utset HA; Vieira MC; Wrammert J; Ahmed R; Holden-Wiltse J; Topham DJ; Treanor JJ; Ertl HC; Schmader KE; Cobey S; Krammer F; Hensley SE; Greenberg H; He XS; Wilson PC
    Cell Host Microbe; 2019 Mar; 25(3):357-366.e6. PubMed ID: 30795982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza Antigen Engineering Focuses Immune Responses to a Subdominant but Broadly Protective Viral Epitope.
    Bajic G; Maron MJ; Adachi Y; Onodera T; McCarthy KR; McGee CE; Sempowski GD; Takahashi Y; Kelsoe G; Kuraoka M; Schmidt AG
    Cell Host Microbe; 2019 Jun; 25(6):827-835.e6. PubMed ID: 31104946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive B Cell Responses to Influenza Virus Infection in the Lung.
    Takahashi Y; Onodera T; Adachi Y; Ato M
    Viral Immunol; 2017; 30(6):431-437. PubMed ID: 28661720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.